Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Lanvers

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Cancer Chemotherapy and Pharmacology|February 16, 2017
Asparaginase pharmacology: challenges still to be facedClaudia Lanvers-Kaminsky
Pharmacogenomics|November 28, 2017
Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatinClaudia Lanvers-Kaminsky, Giuliano Ciarimboli
Anti-Cancer Drugs|October 21, 2004
In vitro toxicity of bisphosphonates on human neuroblastoma cell linesMarta Vorotnjak, Joachim Boos, Claudia Lanvers-Kaminsky
Anti-Cancer Drugs|June 4, 2011
An in-vitro evaluation of the polo-like kinase inhibitor GW843682X against paediatric malignanciesKristina Spaniol, Joachim Boos, Claudia Lanvers-Kaminsky
Cancer Chemotherapy and Pharmacology|January 20, 2016
Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitorsViktor Arnhold, Joachim Boos, Claudia Lanvers-Kaminsky
Anticancer Research|July 5, 2018
Preclinical Evaluation of Combined Topoisomerase and Proteasome Inhibition Against Pediatric MalignanciesEdvin Destanovic, Joachim Boos, Claudia Lanvers-Kaminsky
Cancer Chemotherapy and Pharmacology|August 13, 2002
c-KIT-expressing Ewing tumour cells are insensitive to imatinib mesylate (STI571)Marc Hotfilder, Claudia Lanvers, Heribert Jürgens, et al.
Anti-Cancer Drugs|February 12, 2010
Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell linesHenning Lünenbürger, Claudia Lanvers-Kaminsky, Birgit Lechtape, et al.
Scientific Reports|October 30, 2020
Bioanalysis of doxorubicin aglycone metabolites in human plasma samples-implications for doxorubicin drug monitoringChristian Siebel, Claudia Lanvers-Kaminsky, Gudrun Würthwein, et al.
Anti-Cancer Drugs|August 19, 2006
Cytotoxicity of treosulfan and busulfan on pediatric tumor cell linesClaudia Lanvers-Kaminsky, Alexis Bremer, Uta Dirksen, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|February 16, 2017
Asparaginase pharmacology: challenges still to be facedClaudia Lanvers-Kaminsky
Pharmacogenomics|November 28, 2017
Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatinClaudia Lanvers-Kaminsky, Giuliano Ciarimboli
Anti-Cancer Drugs|October 21, 2004
In vitro toxicity of bisphosphonates on human neuroblastoma cell linesMarta Vorotnjak, Joachim Boos, Claudia Lanvers-Kaminsky
Anti-Cancer Drugs|June 4, 2011
An in-vitro evaluation of the polo-like kinase inhibitor GW843682X against paediatric malignanciesKristina Spaniol, Joachim Boos, Claudia Lanvers-Kaminsky
Cancer Chemotherapy and Pharmacology|January 20, 2016
Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitorsViktor Arnhold, Joachim Boos, Claudia Lanvers-Kaminsky
Anticancer Research|July 5, 2018
Preclinical Evaluation of Combined Topoisomerase and Proteasome Inhibition Against Pediatric MalignanciesEdvin Destanovic, Joachim Boos, Claudia Lanvers-Kaminsky
Cancer Chemotherapy and Pharmacology|August 13, 2002
c-KIT-expressing Ewing tumour cells are insensitive to imatinib mesylate (STI571)Marc Hotfilder, Claudia Lanvers, Heribert Jürgens, et al.
Anti-Cancer Drugs|February 12, 2010
Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell linesHenning Lünenbürger, Claudia Lanvers-Kaminsky, Birgit Lechtape, et al.
Scientific Reports|October 30, 2020
Bioanalysis of doxorubicin aglycone metabolites in human plasma samples-implications for doxorubicin drug monitoringChristian Siebel, Claudia Lanvers-Kaminsky, Gudrun Würthwein, et al.
Anti-Cancer Drugs|August 19, 2006
Cytotoxicity of treosulfan and busulfan on pediatric tumor cell linesClaudia Lanvers-Kaminsky, Alexis Bremer, Uta Dirksen, et al.
Pageof 6